Requirement of retinoids for the expression of CD38 on human hematopoietic progenitors in vitro

Cytotherapy

Volumn 1, Issue 6, 1999, Pages 455-468

  Muench, M O ^a   Barcena, A ^a   Ohkubo, T ^a   Harrison, M R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

All trans retinoic acid; CD34; CD38; Colony forming unit; Retinoids; Stem cells

Indexed keywords

EID: 0000933148     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/0032472031000141305     Document Type: Article

References (57)

1. Howard M, Grimaldi JC, Bazan JF et al. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 1993;262:1056-9.
2. 2+ channel. Nature 1993;364:76-9.
3. Lund FE, Yu N, Kim KM et al. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. J Immunol 1996;157:1455-67.
4. Grimaldi JC, Balasubramanian S, Kabra NH et al. CD38-mediated ribosylation of proteins. J Immunol 1995;155:811-7.
5. Kumagai M, Coustan-Smith E, Murray DJ et al. Ligation of CD38 suppresses human B lyinphopoicsis..J Exp Med 1995; 181:1101-10.
6. Silvennoinen O, Nishigaki H, Kitanaka A et al. CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of svk tyrosine kinase, and phosphorylation of phospholipase C-gainma and phosphatidylinositol 3-kinase J Immunol 1996;156:100-7.
7. Deaglio S, Dianzani U, IIorenstcin AL et al. Human CD38 ligand. A 120-KDA protein predominantly expressed on endothelial cells. J Immunol 1996;156:727-34.
8. Malavasi F, Funaro A, Roggero S et al. Human CD38: a glycoprotein in search of a function. Immunol Today 1994; 15:95-7.
9. +CD38 progenitor cells. Blood 1991;77:1218-27.
10. +CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood 1996;87:5196-206.
11. +CD38 cells in cord blood and bone marrow. Blood 1995;86:3745-53.
12. +, CD38 bone marrow, progenitors during human fetal development. Blood 1995;86:710-8.
13. + human fetal liver progenitors with a high proliferative potential. Blood 1994;83:3170-81.
14. + lineage-cells in human thymic organ culture. J Exp Med 1994;180:123-32.
15. Drach J, McQueen T, Engel H et al. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha. Cancer Res 1994; 54: 1746-52.
16. Mehta K, McQueen T, Manshouri T et al. Involvement of retinoic acid receptor-α-mediated signaling pathway in induction of CD38 cell-surface antigen. Blood 1997;89:3607-14.
17. Drach J, Zhao S, Malavasi F et al. Rapid induction of CD38 antigen on myeloid leukemia cells by all-trans-retinoic acid. Biochem Biophys Res Comm 1993;195:545-50.
18. - progenitor cells in long-term cultures and semisolid assays. Blood 1993;81:2916-24.
19. Hao Q-L, Thiemann FT, Petersen D et al. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 1996;88:3306-13.
20. Civin CI, Almeida-Porada G, Lee MJ et al. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow step cells in vivo. Blood 1996;88:4102-9.
21. Muench MO, Roncarolo MG, Menon S et al. FLK-2/FLT-3 ligand (FL) regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 1995;85:963-72.
22. Namikawa R, Muench MO, de Vries JE et al. The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 1996;87:1881-90.
23. Muench MO, Roncarolo M-G, Rosnet O et al. Colony-forming cells expressing high levels of CD34 are the main targets for granulocyte colony-stimulating factor and macrophage colony-stimulating factor in the human fetal liver. Exp Hematol 1997;25:277-87.
24. Wyss R, Bucheli F. Determination of endogenous levels of 13-cis-retinoic acid (isotretinoin), all-trans-retinoic acid (tretinoin) and their 4-oxo metabolites in human and animal plasma by high-performance liquid chromatography with automated column switching and ultraviolet detection. J Chromatogr B 1997;700:31-47.
25. +/++ cells for transplantation. Bone Marrow Transplant. 1999; 24:451-62.
26. ++CD38 fetal liver cells. Exp Hematol 1999; 27:1428-39.
27. Muench MO, Shieh J-H. In vitro development of megakaryocytes and platelets. In: Koller MR, Palsson BO, Masters JRW, editors. Primary Hematopoietic Cells. Boston: Kluwer Academic Publishers; 1999; pp. 287-315.
28. Bradley TR, Hodgson GS. Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood 1979;54: 1446-50.
29. Ross AC. Overview of retinoid metabolism. J Nutr 1993; 123: 346-50.
30. Civin CI, Strauss LC, Brovall C et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KGla cells. J Immunol 1984;133:157-65.
31. Di Giusto D, Chen S, Combs J et al. Human fetal bone anarrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 1994; 84:421-32.
32. + CD38 human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA 1993;90:8707-11.
33. Rusten LS, Jacobsen SEW, Kaalhus O et al. Functional differences between CD38 and DR subfractions of CD34 bone marrow cells. Blood 1994;84:1473-81.
34. Humeau L, Chabannon C, Firpo .MT et al. Successful reconstitution of human hematopoiesis in the SLID-hu mouse by genetically modified, highly enriched progenitors isolated from fetal liver. Blood 1997;90:3496-506.
35. Prosper F, Stroncek D, Verfaillie CM. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. Blood 1996;88:2033-12.
36. Allenby G, Bocquel MT, Saunders M et al. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 1993;90:30-4.
37. Norman AW. Identification of a unique nuclear receptor for 9-cis-retinoic acid. Nutr Rev 1992;50:230-1.
38. Kishimoto H, Hoshino S, Ohori M et al. Molecular mechanism of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron. J Biol Chem 1998;273:15429-34.
39. Periquet B, Lambert W, Garcia J et al. Increased concentrations of endogenous 13-cis- and all-trans-retinoic acids in diffuse idiopathic skeletal hyperostosis, as demonstrated by HPLC. Clin Chim Acta 1991;203:57-65.
40. Lehman PA, Franz TJ. A sensitive high-pressure liquid chromatography/particle beam/mass spectrometry assay for the determination of all-trans-retinoic acid and 13 -cis-retinoic acid in human plasma. J Pharm Sci 1996;85:287-90.
41. Tang GW, Russell RM 13-cis-retinoic acid is an endogenous compound in human serum..J Lipid Res 1990;31:175-82.
42. Kim YW, Sharma RP, Li JK. Characterization of heterologously expressed recombinant retinoic acid receptors with natural or synthetic retinoids. J Biochem Toxicol 1994;9: 225-34.
43. Repa .JJ, Hanson KK, Clagett-Dame M. All-trans-retinol is a ligand for the retinoic acid receptors. Proc: Natl Acad. Sci USA 1993; 90:7293-7.
44. + BM cells. Ann Hematol 1993;66:61-6.
45. Tocci A, Parolini I, Gabbianelli M et al. Dual action of retinoic acid on human embryonic/fetal hematopoiesis: blockade of primitive progenitor proliferation and shift from multipotent/ erythroid/monocytic to granulocytic differentiation program. Blood 1996;88:2878-88.
46. Visani G, Zauli G, Tosi P et al. All-trans-retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients. Leukemia 1994;8:2183-7.
47. Labbaye C, Valtieri M, Testa U et al. Retinoic acid down-modulates erythroid differentiation and GATA1 expression in purified adult-progenitor culture. Blood 1994;83:651-6.
48. + erythroid progenitor cells. Blood 1996;87:1728-36.
49. + hematopoietic progenitor cells: Involvcanent of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells. Exp Hematol 1999;27:642-53.
50. Douer D, Koeffler P. Retinoic acid enhances Colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro. Exp Cell Res 1982; 138:193-8.
51. + haemopoietic progenitor cells. Br J Haematol 1995;90:274-82.
52. Muench MO, Guy Z, Moore ,MAS. Ex vivo differentiation therapy as a method of leukemic cell purging in murine bone marrow expansion cultures. Cancer Res 1992; 52:6576-82.
53. Jacobsen SE, Fahlman C, Blomhoff HK et al. All-trans- and 9-cis-retinoic acid: potent direct inhibitors of primitive murine hematopoietic progenitors in vitro. J Exp Med 1994; 179: 1665-70.
54. + human hematopoietic progenitor cells. Blood 1994;84:2940-5.
55. + cells without recruitment into cell cycle. Br J Haematol 1998;103:343-50.
56. Melnick A, Licht JD. Deconstructing a disease: RAR, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999;93:3167-215.
57. Randall TD, Lund FE, Howard MC et al. Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells. Blood 1996;87:4057-67.